In vitro viability effects on apheresis and buffy-coat derived platelets administered through infusion pumps
Per Sandgren,1,2 Veronica Berggren,3 Carl Westling,1,2 Viveka Stiller1 1Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, 2Department of Laboratory Medicine, Karolinska Institutet, 3Department of Neonatology, Karolinska University Hospital, Stockholm, Sweden...
Main Authors: | Sandgren P, Berggren V, Westling C, Stiller V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-12-01
|
Series: | International Journal of Clinical Transfusion Medicine |
Online Access: | http://www.dovepress.com/in-vitro-viability-effects-on-apheresis-and-buffy-coat-derived-platele-peer-reviewed-article-IJCTM |
Similar Items
-
Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods
by: Singh Ravindra, et al.
Published: (2009-01-01) -
Platelets from platelet-rich-plasma versus buffy-coat-derived platelets: what is the difference?
by: Hans Gulliksson
Published: (2012-01-01) -
A case report of apheresis granulocyte concentrates and the whole blood-derived pooled buffy coat transfusions in a neutropenic hematopoietic stem cell transplant recipient
by: Abhaykumar Malind Gupta, et al.
Published: (2021-01-01) -
Apheresis platelets in additive solution: Is it a good alternative to conventional group-specific apheresis platelets?
by: Amit Agrawal
Published: (2017-01-01) -
Clinical outcome of platelet transfusion using platelet-rich plasma-derived platelets and buffy coat-removed platelets in patients with dengue fever – A comparison
by: Jyothis Purushothaman, et al.
Published: (2020-01-01)